Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11499151 Methods and systems for analyzing guide RNA molecules

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Editas Medicine

Current Assignee

Editas Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 15, 2022

Patent Application Number

16608411

Date Filed

April 27, 2018

Patent Citations

US Patent 10100291 Mutant Cas9 proteins

US Patent 10066233 Method of modulating cell resistance

US Patent 10077453 CAS9 proteins including ligand-dependent inteins

US Patent 10093910 Engineered CRISPR-Cas9 nucleases

US Patent 10415061 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

US Patent 10421980 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

US Patent 10428319 Engineered Cas9 nucleases

US Patent 10428352 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

...

Patent Primary Examiner

CPC Code

The present disclosure relates to methods of assessing a sample of guide RNAs (gRNAs).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11499151 Methods and systems for analyzing guide RNA molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool